These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30252550)

  • 1. Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia.
    Wang S; Seth D; Ezaldein H; Tripathi R; Merati M; Muakkassa F; Scott J
    J Dermatolog Treat; 2019 Aug; 30(5):489-491. PubMed ID: 30252550
    [No Abstract]   [Full Text] [Related]  

  • 2. Photobiomodulation therapy for androgenetic alopecia: A clinician's guide to home-use devices cleared by the Federal Drug Administration.
    Dodd EM; Winter MA; Hordinsky MK; Sadick NS; Farah RS
    J Cosmet Laser Ther; 2018 Jun; 20(3):159-167. PubMed ID: 29020478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the FDA's 510(k) approvals process for electromagnetic devices used in body contouring.
    Wang S; Manudhane A; Ezaldein HH; Scott JF
    J Dermatolog Treat; 2019 Nov; 30(7):727-729. PubMed ID: 30614316
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial.
    Suchonwanit P; Chalermroj N; Khunkhet S
    Lasers Med Sci; 2019 Aug; 34(6):1107-1114. PubMed ID: 30569416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powered muscle stimulators: an investigation into newly FDA 510(k) approved devices marketed for muscle toning and esthetic benefit.
    Manudhane AP; Wang S; Ezaldein HH; Scott JF
    J Dermatolog Treat; 2020 Mar; 31(2):200-203. PubMed ID: 30799667
    [No Abstract]   [Full Text] [Related]  

  • 9. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
    Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss.
    Gupta AK; Daigle D
    J Dermatolog Treat; 2014 Apr; 25(2):162-3. PubMed ID: 23924031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level laser/light therapy for androgenetic alopecia.
    Gupta AK; Lyons DC; Abramovits W
    Skinmed; 2014; 12(3):145-7. PubMed ID: 25134310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter light therapy for acne: a cross-sectional retrospective analysis.
    Seth D; Wang S; Ezaldein HH; Merati M; Scott JF
    Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
    Lueangarun S; Visutjindaporn P; Parcharoen Y; Jamparuang P; Tempark T
    J Clin Aesthet Dermatol; 2021 Nov; 14(11):E64-E75. PubMed ID: 34980962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level laser therapy as a treatment for androgenetic alopecia.
    Afifi L; Maranda EL; Zarei M; Delcanto GM; Falto-Aizpurua L; Kluijfhout WP; Jimenez JJ
    Lasers Surg Med; 2017 Jan; 49(1):27-39. PubMed ID: 27114071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
    Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
    Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.
    Jimenez JJ; Wikramanayake TC; Bergfeld W; Hordinsky M; Hickman JG; Hamblin MR; Schachner LA
    Am J Clin Dermatol; 2014 Apr; 15(2):115-27. PubMed ID: 24474647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level laser therapy and hair regrowth: an evidence-based review.
    Zarei M; Wikramanayake TC; Falto-Aizpurua L; Schachner LA; Jimenez JJ
    Lasers Med Sci; 2016 Feb; 31(2):363-71. PubMed ID: 26690359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia.
    Galadari H; Shivakumar S; Lotti T; Wollina U; Goren A; Rokni GR; Grabbe S; Goldust M
    Lasers Med Sci; 2020 Aug; 35(6):1239-1244. PubMed ID: 32162134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
    Peters W; Pellerin C; Janney C
    Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level laser (light) therapy (LLLT) for treatment of hair loss.
    Avci P; Gupta GK; Clark J; Wikonkal N; Hamblin MR
    Lasers Surg Med; 2014 Feb; 46(2):144-51. PubMed ID: 23970445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.